CV Sciences, Inc. (CVSI)

OTCMKTS · Delayed Price · Currency is USD
0.0478
+0.0038 (8.64%)
Oct 30, 2024, 9:30 AM EDT
27.47%
Market Cap 8.57M
Revenue (ttm) 15.85M
Net Income (ttm) -2.53M
Shares Out 184.79M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 75,000
Open 0.0478
Previous Close 0.0440
Day's Range 0.0478 - 0.0478
52-Week Range 0.0300 - 0.1000
Beta 0.60
Analysts n/a
Price Target n/a
Earnings Date Nov 13, 2024

About CV Sciences

CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. The company offers its products under the PlusCBD, ProCBD, HappyLane, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for... [Read more]

Sector Healthcare
Founded 2010
Employees 43
Stock Exchange OTCMKTS
Ticker Symbol CVSI
Full Company Profile

Financial Performance

Financial Statements

News

Marijuana Stock Movers For October 23, 2024

GAINERS: Leafbuyer Techs (OTC: LBUY) shares closed up 100.00% at $0.00 4Front Ventures (OTC: FFNTF) shares closed up 24.89% at $0.06 Pharmadrug (OTC: LMLLF) shares closed up 15.85% at $0.02 Body an...

8 days ago - Benzinga

Cannabis Stock Gainers And Losers From October 4, 2024

GAINERS: CLS Holdings USA (OTC: CLSH) shares closed up 23.72% at $0.05 CordovaCann (OTC: LVRLF) shares closed up 16.96% at $0.07 4Front Ventures (OTC: FFNTF) shares closed up 10.82% at $0.05 CV Sci...

27 days ago - Benzinga

CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements

Designed to elevate focus, mood, energy, and metabolism with clinically proven wellness ingredients Available in three variations - Clarity, Peace, and ReShape SAN DIEGO , Aug. 27, 2024 /PRNewswire/ -...

2 months ago - PRNewsWire

Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024

GAINERS: Target Group (OTC: CBDY) shares closed up 33.33% at $0.00 CNBX Pharmaceuticals (OTC: CNBX) shares closed up 28.57% at $0.01 Nextleaf Solutions (OTC: OILFF) shares closed up 19.05% at $0.07...

2 months ago - Benzinga

CV Sciences, Inc. (CVSI) Q2 2024 Earnings Call Transcript

CV Sciences, Inc. (OTCQB:CVSI) Q2 2024 Earnings Conference Call August 13, 2024 10:00 AM ETCompany ParticipantsBrendan Hawkins - Investor RelationsJoseph...

2 months ago - Seeking Alpha

CV Sciences, Inc. Reports Second Quarter 2024 Financial Results

SAN DIEGO , Aug. 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

2 months ago - PRNewsWire

CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024

SAN DIEGO , Aug. 7, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

3 months ago - PRNewsWire

CV Sciences, Inc. (CVSI) Q1 2024 Earnings Call Transcript

CV Sciences, Inc. (OTCQB:CVSI) Q1 2024 Earnings Conference Call May 14, 2024 10:00 AM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participants...

6 months ago - Seeking Alpha

CV Sciences, Inc. Reports First Quarter 2024 Financial Results

SAN DIEGO , May 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

6 months ago - PRNewsWire

CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER

SAN DIEGO , May 13, 2024 /PRNewswire/ -- CV Sciences, Inc.  (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

6 months ago - PRNewsWire

CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024

SAN DIEGO , May 8, 2024 /PRNewswire/ --  CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ot...

6 months ago - PRNewsWire

CV Sciences, Inc. (CVSI) Q4 2023 Earnings Call Transcript

CV Sciences, Inc. (CVSI) Q4 2023 Earnings Call Transcript

7 months ago - Seeking Alpha

CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results

SAN DIEGO , March 28, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ...

7 months ago - PRNewsWire

CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews

Pet Hip and Joint Health Chews and Pet Calming Care Chews improve the physical and emotional well-being of dogs SAN DIEGO , March 26, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company...

7 months ago - PRNewsWire

CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024

SAN DIEGO , March 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in nutraceuticals an...

8 months ago - PRNewsWire

CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution

SAN DIEGO , Dec. 12, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

11 months ago - PRNewsWire

CV Sciences, Inc. (CVSI) Q3 2023 Earnings Call Transcript

CV Sciences, Inc. (OTCQB:CVSI) Q3 2023 Earnings Conference Call November 14, 2023 10:00 AM ET Company Participants Brendan Hawkins - Investor Relations Joseph Dowling - Chief Executive Officer Joerg G...

1 year ago - Seeking Alpha

CV Sciences, Inc. Reports Third Quarter 2023 Financial Results

SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

1 year ago - PRNewsWire

CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023

SAN DIEGO , Nov. 9, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ot...

1 year ago - PRNewsWire

CV Sciences, Inc. Launches Reserve Sleep Gummies

Premium sleep aid supports better sleep by combining melatonin and cannabinoids SAN DIEGO , Sept. 5, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "...

1 year ago - PRNewsWire

CV Sciences, Inc. (CVSI) Q2 2023 Earnings Call Transcript

CV Sciences, Inc. (OTCQB:CVSI) Q2 2023 Earnings Conference Call August 14, 2023 10:00 AM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participa...

1 year ago - Seeking Alpha

CV Sciences, Inc. Reports Second Quarter 2023 Financial Results

SAN DIEGO , Aug. 14, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

1 year ago - PRNewsWire

CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023

SAN DIEGO , Aug. 1, 2023 /PRNewswire/ --  CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

1 year ago - PRNewsWire

CV Sciences to Participate in LD Micro Invitational Conference

13th invitational event welcomes over 150 companies to over 800 attendees SAN DIEGO , June 1, 2023 /PRNewswire/ --  CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), ...

1 year ago - PRNewsWire

CV Sciences, Inc. (CVSI) Q1 2023 Earnings Call Transcript

CV Sciences, Inc. (OTCQB:CVSI) Q1 2023 Earnings Conference Call May 15, 2023 10:00 AM ET Company Participants Joseph Dowling - CEO, Secretary and Director Joerg Grasser - CFO Conference Call Participa...

1 year ago - Seeking Alpha